Science Explorer Interactive view Map
Company · Tsukuba · Japan

ID Pharma (Japan)

dnavec.co.jp/enROR OpenAlex
World rank, all time
#31,459
of 42,892
Rank in Japan
#1,300
of 2,112
Research works
143
▼ 52% vs 2013–17
Citations
5.8k
40.2 per fractional work
Top-10% rate
20.3%
record average 16.5%
Open access
39%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.26× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.85× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 16.76× its world share, 1 worksImmunology and Micro…Neuroscience: 5.88× its world share, 1 worksNeuroscienceChemistry: 0.79× its world share, 0 worksChemistryEngineering: 1.32× its world share, 1 worksEngineeringEnvironmental Science: 0.50× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.53× its world share, 0 worksMaterials ScienceHealth Professions: 2.01× its world share, 0 worksHealth ProfessionsMedicine: 1.05× its world share, 1 worksMedicineEconomics, Econometrics and Finance: 1.15× its world share, 0 worksEconomics, Econometr…Psychology: 0.23× its world share, 0 worksPsychologySocial Sciences: 0.25× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 16.8×. Every wedge is a field page.

Who are the top researchers at ID Pharma (Japan)?

Ranked on the composite score, Mamoru Hasegawa and Makoto Inoue lead among researchers whose main affiliation is ID Pharma (Japan).

  1. 1 Mamoru Hasegawa Japan · #481,988 worldwide 95 citations · 29 works
  2. 2 Makoto Inoue Japan · #798,616 worldwide 118 citations · 70 works
All ranked researchers at ID Pharma (Japan)

Which keywords describe research at ID Pharma (Japan)?

By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, Genomic Integration, AAV, Viral Vectors, Vaccine, Epidemiology, Pathogenesis and Immune Response.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Gene Therapy26▲ 69×5 topics
  2. Epidemiology20▲ 3.4×29 topics
  3. Genomic Integration18▲ 122×2 topics
  4. AAV17▲ 182×1 topic
  5. Viral Vectors17▲ 182×1 topic
  6. Vaccine15▲ 26×8 topics
  7. Pathogenesis11▲ 14×9 topics
  8. Immune Response10▲ 12×12 topics
  9. Inflammation8▲ 2.2×25 topics
  10. Transcriptional Regulation6▲ 18×6 topics
  11. Embryonic Stem Cells6▲ 60×2 topics
  12. Differentiation6▲ 54×2 topics
  13. Oxidative Stress6▲ 2.2×21 topics
  14. Pluripotent Stem Cells6▲ 56×2 topics
  15. Gene Silencing5▲ 30×2 topics
  16. Induced Pluripotent Stem Cells5▲ 102×1 topic
  17. Reprogramming5▲ 102×1 topic
  18. Infection5▲ 12×3 topics
  19. Innate Immunity5▲ 9.4×4 topics
  20. Genome Engineering5▲ 55×1 topic
  21. Norovirus5▲ 55×1 topic
  22. RNA Interference5▲ 29×1 topic
  23. RNA-Guided5▲ 55×1 topic
  24. Rotavirus5▲ 55×1 topic
  25. siRNA Delivery5▲ 43×1 topic
  26. Cancer Immunotherapy4▲ 22×3 topics
  27. Immunity4▲ 8.0×7 topics
  28. Immunotherapy4▲ 4.1×6 topics
  29. Viral Pathogenesis4▲ 33×3 topics
  30. Vaccine Development4▲ 7.9×4 topics
  31. Metagenomics3▲ 19×2 topics
  32. Cell Signaling3▲ 6.9×4 topics
  33. Coronavirus3▲ 20×2 topics
  34. Tumor Regression3▲ 26×2 topics
  35. Macular Degeneration3▲ 17×2 topics
  36. Nipah Virus3▲ 85×1 topic
  37. Paramyxovirus3▲ 85×1 topic
  38. Genomic Sequencing3▲ 14×2 topics
  39. Antigen Presentation3▲ 20×2 topics
  40. Circovirus3▲ 54×1 topic

Which research topics does ID Pharma (Japan) publish most on?

By volume in 2022–2025: Advanced Chemical Sensor Technologies, T-cell and B-cell Immunology, Advanced Photonic Communication Systems and Optical Network Technologies.

Advanced Chemical Sensor…0Advanced Chemical Sensor Technologies: 0 fractional worksT-cell and B-cell Immuno…0T-cell and B-cell Immunology: 0 fractional worksAdvanced Photonic Communication Systems: 0 fractional worksOptical Network Technolo…0Optical Network Technologies: 0 fractional worksAdvanced Optical Network…0Advanced Optical Network Technologies: 0 fractional worksImmune cells in cancer: 0 fractional worksCRISPR and Genetic Engineering: 0 fractional worksMultidisciplinary Resear…0Multidisciplinary Research Papers Compilation: 0 fractional worksNeural dynamics and brain function: 0 fractional worksAir Quality Monitoring and Forecasting: 0 fractional works
Biomedical EngineeringImmunologyElectrical and Electronic EngineeringMolecular Biology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Advanced Chemical Sensor Technologies Biomedical Engineering 0 works
  2. 2 T-cell and B-cell Immunology Immunology 0 works
  3. 3 Advanced Photonic Communication Systems Electrical and Electronic Engineering 0 works
  4. 4 Optical Network Technologies Electrical and Electronic Engineering 0 works
  5. 5 Advanced Optical Network Technologies Electrical and Electronic Engineering 0 works
  6. 6 Immune cells in cancer Immunology 0 works
  7. 7 CRISPR and Genetic Engineering Molecular Biology 0 works
  8. 8 Multidisciplinary Research Papers Compilation General Social Sciences 0 works
  9. 9 Neural dynamics and brain function Cognitive Neuroscience 0 works
  10. 10 Air Quality Monitoring and Forecasting Environmental Engineering 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.2%not open60.8%

World: 28% of research is openly available.

with international co-authors19.0%domestic only81.0%

World: 19% is written across borders.

How has ID Pharma (Japan)'s research output changed?

Output in 2018–2022 was 52% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tsukuba

All research institutions in Tsukuba

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.